Transthyretin Amyloidosis: Information for Patients and Family | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: Education

Scientific literature and patient education texts

Back to Education / Patient Education

Transthyretin Amyloidosis: Information for Patients and Family

key information

source: Amyloidosis Support Groups

year: N/A

summary/abstract:

What is transthyretin amyloidosis?

Transthyretin (TTR) amyloidosis is a disease caused by the abnormal accumulation of protein molecule in body tissues. These protein accumulations or “amyloid deposits” are made from a blood protein. TTR, which normally transport thyroid hormone and vitamin A to the body tissues. When an inherited defect in the TTR protein occurs, this abnormal form of TTR has the tendency to accumulate in tissues such as the heart, kidneys, nerves and intestine. The presence of these deposits interferes with the normal functions of the organs, and as the deposits enlarge more tissue damage occurs and the disease (TTR amyloidosis) worsens.

 

What is transthyretin?

TTR is a normal blood protein. Its function is to carry thyroid hormone and vitamin A to tissues where they are needed for normal metabolism. Like all proteins TTR is made from 20 different amino acid which are linked end to end to make large molecule.

read more

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close